Answer
Apr 01, 2026 - 09:55 AM
For adults, Repatha is typically dosed at 140 mg subcutaneously every two weeks, or 420 mg once monthly for primary hyperlipidemia, heterozygous familial hypercholesterolemia (HeFH), and cardiovascular risk reduction. For homozygous familial hypercholesterolemia (HoFH), the starting dose is 420 mg monthly, which may be increased to 420 mg every two weeks if needed. Having flexible dosing options allows for tailored treatment depending on the patient's condition.
